Rankings
▼
Calendar
PHAT Q2 2018 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PHAT
Phathom Pharmaceuticals, Inc.
$831M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$253,000
Net Income
-$257,000
EPS (Diluted)
$-0.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$226,000
Free Cash Flow
-$226,000
Stock-Based Comp.
$0
← FY 2018
All Quarters
Q3 2018 →
